141 related articles for article (PubMed ID: 7353382)
1. Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.
Sherrard DJ; Coburn JW; Brickman AS; Singer FR; Maloney N
Contrib Nephrol; 1980; 18():92-7. PubMed ID: 7353382
[No Abstract] [Full Text] [Related]
2. Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
Brickman AS; Coburn JW; Sherrard DJ; Wong EG; Norman AW; Singer FR
Contrib Nephrol; 1980; 18():29-41. PubMed ID: 7353378
[No Abstract] [Full Text] [Related]
3. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
4. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
Voigts AL; Felsenfeld AJ; Llach F
Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
[TBL] [Abstract][Full Text] [Related]
5. Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?
Teitelbaum SL; Bergfeld MA; Freitag J; Hruska KA; Slatopolsky E
J Clin Endocrinol Metab; 1980 Aug; 51(2):247-51. PubMed ID: 6893204
[No Abstract] [Full Text] [Related]
6. Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy.
Prior JC; Cameron EC; Ballon HS; Lirenman DS; Moriarty MV; Price JD
Am J Med; 1979 Oct; 67(4):583-9. PubMed ID: 386792
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of 1 alpha-hydroxy-and 1,25-dihydroxyvitamin D3 in the treatment of renal bone disease.
Kanis JA; Russell RG; Cundy T; Earnshaw M; Woods CG; Smith R; Heynen G
Contrib Nephrol; 1980; 18():12-28. PubMed ID: 7353370
[TBL] [Abstract][Full Text] [Related]
8. The use of metabolites and analogues of vitamin D in prospective renal transplant recipients.
Cundy T; Kanis JA; Fraher L; Clemens TL; O'Riordan JL
Clin Nephrol; 1981 May; 15(5):240-5. PubMed ID: 7018772
[No Abstract] [Full Text] [Related]
9. The action of 1,25 (OH)2D3 on turnover kinetic, remodelling surfaces and structure of trabecular bone in chronic renal failure.
Delling G; Lühmann H; Bulla M; Fuchs C; Henning HV; Jansen JL; Kohnle W; Schulz W
Contrib Nephrol; 1980; 18():105-21. PubMed ID: 7353369
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy.
Ahmed KY; Varghese Z; Wills MR; Meinhard EA; Moorhead JF
Lancet; 1978 Mar; 1(8065):629-32. PubMed ID: 76168
[TBL] [Abstract][Full Text] [Related]
11. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
[TBL] [Abstract][Full Text] [Related]
12. The role of vitamin D in renal bone disease.
Stanbury SW
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():25s-30s. PubMed ID: 342146
[No Abstract] [Full Text] [Related]
13. Editorial: Azotaemic renal osteodystrophy.
Med J Aust; 1974 Jun; 1(22):864-5. PubMed ID: 4851493
[No Abstract] [Full Text] [Related]
14. [Bone changes in chronic renal insufficiency].
Ritz E; Krempien B; Prager P; Bommer J; Mehls O; Andrassy K
Med Klin; 1975 Jun; 70(26):1112-24. PubMed ID: 772387
[No Abstract] [Full Text] [Related]
15. Treatment of renal bone disease.
Lancet; 1979 Dec 22-29; 2(8156-8157):1339-40. PubMed ID: 92678
[No Abstract] [Full Text] [Related]
16. A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D.
Coburn JW; Sherrard DJ; Brickman AS; Wong EG; Norman AW; Singer FR
Contrib Nephrol; 1980; 18():172-83. PubMed ID: 7353374
[No Abstract] [Full Text] [Related]
17. 'One-alpha'.
Lancet; 1978 May; 1(8071):973-4. PubMed ID: 76898
[No Abstract] [Full Text] [Related]
18. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
Brickman AS; Norman AW
Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
[No Abstract] [Full Text] [Related]
19. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
[No Abstract] [Full Text] [Related]
20. [Vitamin D and renal failure (author's transl)].
Fuss M; Corvilain J
Rev Med Brux; 1981 Apr; 2(4):441-5. PubMed ID: 7291796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
